B7-H3 expression associates with tumor invasion and patient's poor survival in human esophageal cancer.
Lujun Chen(Soochow University), Jingting Jiang(Soochow University), Changping Wu(Soochow University), Honglei Pei(Soochow University), Jun Chen(University of Shanghai for Science and Technology), Bin Xu(Jiangsu University), Liangrong Shi(Central South University), Qi Wang(Second Affiliated Hospital of Zhejiang University), Jing Sun(Central South University), Guangbo Zhang(Soochow University), Wei Zhou(Broad Institute)
PubMed
January 1, 2015
Cited by 62
Related Papers
Pembrolizumab versus investigator-choice chemotherapy for ipilimumab-refractory melanoma (KEYNOTE-002): a randomised, controlled, phase 2 trial
|The Lancet Oncology|2015|1.6k
Randomized, Double-Blind, Placebo-Controlled Phase III Trial of Apatinib in Patients With Chemotherapy-Refractory Advanced or Metastatic Adenocarcinoma of the Stomach or Gastroesophageal Junction
|Journal of Clinical Oncology|2016|1k
A novel protein encoded by a circular RNA circPPP1R12A promotes tumor pathogenesis and metastasis of colon cancer via Hippo-YAP signaling
|Molecular Cancer|2019|718
Inflammation induced by incomplete radiofrequency ablation accelerates tumor progression and hinders PD-1 immunotherapy
|Nature Communications|2019|277
Targeting p21-activated kinase 1 (PAK1) to induce apoptosis of tumor cells
|Proceedings of the National Academy of Sciences|2011|256